Physician profile
Jill Rayes
NPI 1568983468
$2,271.77
in general payments reported to CMS, 2019-2025
23 companies · $595 in 2025
The $595 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $132 · 2023: $856 · 2024: $688 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,139.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $434.14 | 2023-2025 | Gemtesa |
| Myriad Genetic Laboratories, INC. | $294.78 | 2023 | Prolaris |
| Photocure INC | $192.65 | 2022-2025 | Cysview |
| Dexcom, INC. | $154.25 | 2024 | Dexcom G7 Gss (161) |
| Teva Pharmaceuticals USA, INC. | $124.99 | 2024 | Austedo Xr |
| Actelion Pharmaceuticals US, INC. | $124.99 | 2023 | Opsumit, Uptravi |
| Urogen Pharma, INC. | $121.70 | 2022-2025 | Jelmyto |
| Procept Biorobotics Corporation | $113.33 | 2025 | |
| Lilly USA, LLC | $95.43 | 2024 | Zepbound |
| Endo Pharmaceuticals INC. | $88.18 | 2022-2023 | Xiaflex, Aveed |
| 180 Medical, INC. | $78.15 | 2023-2025 | Cure Ultra Catheter |
| Astellas Pharma US INC | $67.10 | 2023 | Myrbetriq |
| Boston Scientific Corporation | $66.64 | 2023-2025 | Ams 700, Ams Ambicor |
| Bayer Healthcare Pharmaceuticals INC. | $53.67 | 2022-2024 | |
| Coloplast Corp | $48.99 | 2024-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $47.85 | 2022-2023 | Pylarify |
| Merck Sharp & Dohme LLC | $45.64 | 2023 | Lynparza, Keytruda |
| Hollister Incorporated | $30.80 | 2023 | Infyna Chic |
| Pfizer INC. | $20.76 | 2023 | |
| Calyxo, INC. | $19.84 | 2025 | Cvac Aspiration System |
| Ferring Pharmaceuticals INC. | $18.51 | 2024 | Adstiladrin |
| Endo USA, INC. | $14.77 | 2025 | Xiaflex, Aveed |
| Sagent Pharmaceuticals | $14.61 | 2024 | Glydo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Rayes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.